Methicillin-resistent staphylococcus aureus: Risk factors for high incidence;Staphylococcus aureus resistant a la meticilline: Facteurs responsables de l'endemie

Revue de Medecine Interne

Volumn 21, Issue 4, 2000, Pages 344-352

  Aubry Damon, H ^a,b   Soussy, C J ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Endemic; Methicillin resistant Staphylococcus aureus; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; ENDEMIC DISEASE; EPIDEMIC; INCIDENCE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN RESISTANCE; REVIEW; RISK FACTOR; ARTICLE; DISEASE CARRIER; DRUG EFFECT; EUROPE; HUMAN; PATHOGENICITY; PREVALENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

DISEASE RESERVOIRS; ENDEMIC DISEASES; EUROPE; HUMANS; INCIDENCE; INFECTION CONTROL; METHICILLIN RESISTANCE; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0034177709     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)88937-7     Document Type: Article

References (63)

1. 1 Vincent JL, Suter PM, and the EPIIC study group. The prevalence of nosocomial infection in intensive care units in Europe. Results of the EPIIC study. JAMA 1995 ; 244 : 639-44.
2. 2 Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993 ; 6 : 428-42.
3. 3 Boyce JM. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1990 ; 11 : 639-42.
4. 4 Cookson BD, Phillips I. Epidemic methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1988 ; 21 Suppl C) : 57-65.
5. 5 Mulligan ME, Arbeit RD. Epidemiologic and clinical utility of typing systems for differentiating among strains of methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol 1991 ; 12 : 20-8.
6. 6 Réseau de microbiologie du C.CLIN Paris-Nord et le Groupe de Microbiologistes d'Île-de-France. Surveillance des bactéries multirésistantes à partir du laboratoire en 1997. Bulletin du CLIN Paris-Nord 1998 ; 11 : 4-5.
7. 7 Maple PAC, Hamilton-Miller JMT, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989 ; ii : 537-40.
8. 8 Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994 ; 13 : 50-5.
9. 9 Comité technique national des infections nosocomiales. 100 recommandations pour la surveillance et la prévention des infections nosocomiales. Paris : Documentation du ministère de la Santé ; 1992.
10. 10 Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy C-J, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis 1997 ; 25 : 647-53.
11. 11 Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant vancomycin. Lancet 1997 ; 350 : 1670-3.
12. 12 Ploy MC, Grelaud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in French hospital [Letter]. Lancet 1998 ; 351 : 1212.
13. th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: 1999. p. 651.
14. 14 Vandenbroucke-Grauls C. Epidemiology of staphylococcal infections. An European perspective. J Chemother 1994 ; 6 Suppl 2 : 67-70.
15. 15 Boyce JM. Methicillin-resistant Staphylococcus aureus: a continuing infection control challenge. Eur J Clin Microbiol Infect Dis 1994 ; 13 : 45-9.
16. 16 Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected bone. Antimicrob Agents Chemother 1988 ; 32 : 1320-2.
17. 17 Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987 ; 9 : 1065-78.
18. 18 Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982 ; 97 : 344-50.
19. 19 Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control 1981 ; 2 : 110-6.
20. 20 Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control 1985 ; 13 : 109-14.
21. th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto: 1997. p. 288.
22. 22 Schentag JJ, Hyatt JM, Carr JR, Paladino JA, Birmingham MC, Zimmer GS, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 1998 ; 26 : 1204-14.
23. 23 Tenover FC, Arbeit RD, Archer G, Biddle J, Byrne S, Goering G, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol 1994 ; 32 : 407-15.
24. 24 Walsh TJ, Vlahov D, Hansen SL, Sonnenberg E, Khabbatz R, Gadacz T, et al. Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 1987 ; 8 : 7-14.
25. 25 Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991 ; 91 Suppl 3B : 221-7.
26. 26 Casewell MW, Hill RLR. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986 ; 18 Suppl A : 1-12.
27. 27 Brun-Buisson C, Rauss A, Legrand P, Tondriaux A, Eb F, Sollet JP, et al. Traitement du portage nasal de Staphylococcus aureus par la mupirocine nasale et prévention des infections acquises en réanimation. Étude multicentrique contrôlée. Méd Mal Infect 1994 ; 24 : 1229-39.
28. 28 Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980 ; 93 : 526-32.
29. 29 Projan SJ, Novick RP. The molecular basis of pathogenicity. In: Crossley KB, Archer GL, eds. The staphylococci in human diseases. New York: Churchill Livingston; 1997. p. 58-82.
30. 30 Coia JE, Browning L, Haines L, Birkbeck TH, Platt DJ. Comparison of enterotoxins and hemolysins produced by methicillin-resistant (MRSA) and sensitive (MSA) Staphylococcus aureus. J Med Microbiol 1992 ; 36 : 164-71.
31. 31 Ward TT. Comparison of in vitro adherence of methicillin-sensitive and methicillin-resistant S. aureus to human nasal epithelial cells. J Infect Dis 1992 ; 166 : 400-4.
32. 32 Tankovic J, Aubry-Damon H, Leclercq R. Résistance aux antibiotiques autres que les bêtalactamines chez Staphylococcus aureus. Méd Mal Infect 1997 ; 27 Spécial : 207-16.
33. 33 Locksley RM, Cohen ML, Quinn TC, Tompkins LS, Coyle MB, Kirhara JM, et al. Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission and evolution of nosocomial infection. Ann Intern Med 1982 ; 97 : 317-24.
34. 34 Cluff LE, Reynolds RJ. Management of staphylococcal infections. Am J Med 1965 ; 39 : 812-25.
35. 35 Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978 ; 138 : 1657-9.
36. 36 Jacobson MA, Gellerman H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 1988 ; 85 : 172-9.
37. 37 Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982 ; 97 : 309-17.
38. 38 Brun-Buisson C, Gutmann L, Jarlier V, Nicolas MH, CLIN central de l'Assistance publique de Paris. Contrôle des infections nosocomiales à germes multirésistants. Paris : Documentation du service central de l'hygiène et de la prévention de l'AP-HP ; 1992.
39. 39 Hospital Infection Society and British Society for Antimicrobial Chemotherapy. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and the British Society for Antimicrobial Chemotherapy. J Hosp Infect 1990 ; 16 : 351-77.
40. 40 Frenay HME, Van Leeuwen WJ, de Neeling JH, Schot CS, Rost JA, Verhoef J, et al. Methicillin-resistant Staphylococcus aureus: the role of inter-hospital travel to the Netherlands [Letter]. Br Med J 1994 ; 308 : 58.
41. 41 Pearman JW, Christiansen KJ, Annear DI, Goodwin CS, Metcalf C, Donovan FP, et al. Control of methicillin-resistant Staphylococcus aureus in an Australian metropolitan teaching hospital complex. Med J Austr 1985 ; 142 : 103-8.
42. 42 Rosdahl VT, Kundsen AM. The decline of methicillin-resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991 ; 12 : 83-8.
43. 43 Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991 ; 12 : 46-54.
44. 44 Ayliffe GAJ, Brumfitt W, Casewell MW, Cooke EM, Cookson BD, Duckworth GJ, et al. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986 ; 7 : 193-201.
45. 45 Casewell MW. Epidemiology and control of the "modern" methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986 ; Suppl 7 : 1-11.
46. 46 Carles-Nurit MJ, Christophle B, Broche S, Couby A, Bouziges N, Ramuz M. DNA polymorphisms in methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol 1992 ; 30 : 2092-6.
47. 47 Gillespie MT, Lyon BR, Skurray RA. Typing of methicillin-resistant Staphylococcus aureus by antibiotic resistance phenotypes. J Med Microbiol 1990 ; 31 : 57-64.
48. 48 Bannerman TL, Hancock GA, Tenover FC. Miller JM. Pused-field gel electrophoresis as a remplacement for bacteriophage typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1995 ; 33 : 551-5.
49. 49 Maslow JN, Mulligan ME, Arbeit RD. Molecular epidemiology: the application of contemporary techniques of typing of microorganisms. Clin Infect Dis 1993 ; 17 : 153-64.
50. 50 Kreiswirth B, Kornblum J. Arbeit RD, Eisner W, Maslow JN, MacGeer A, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993 ; 259 : 227-30.
51. 51 Struelens JM, Deplano A, Godard C, Maes N, Serruys E. Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. J Clin Microbiol 1992 ; 30 : 2599-605.
52. 52 Bouvet A, Fournier JM, Audurier A, Branger C, Orsoni A, Girard C. Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. J Clin Microbiol 1990 ; 28 : 1338-41.
53. 53 Jorgensen M, Givney R, Pegler M. Vickery A, Funnell G. Typing multidrug-resistant Staphylococcus aureus: conflicting epidemiological data produced by genotypic and phenotypic methods clarified by phylogenetic analysis. J Clin Microbiol 1996 ; 34 : 398-403.
54. 54 Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 1992 ; 30 : 1654-60.
55. 55 Kizaki M, Kobayashi Y, Ikeda Y. Rapid and sensitive detection of the femA gene Staphylococci by enzymatic detection of polymerase chain reaction (ED-PCR): comparison with standard PCR analysis. J Clin Microbiol 1994 ; 28 : 287-95.
56. 56 Riley TV, Rouse IL. Methicillin-resistant Staphylococcus aureus in Western Australia, 1983-1992. J Hosp Infect 1995 ; 29 : 177-88.
57. 57 Lessing MPA, Jordens JZ, Bowler ICJ. Molecular epidemiology of a multiple strain outbreak of methicillin-resistant Staphylococcus aureus amongst patients and staff. J Hosp Infect 1995 ; 31 : 253-60.
58. 58 Venezia RA, Harris V, Miller C, Peck H, San Antonio M. Investigation of an outbreak of methicillin-resistant Staphylococcus aureus in patients with skin disease using DNA restriction patterns. Infect Control Hosp Epidemiol 1992 ; 1 : 472-6.
59. 59 Blumberg HM, Rimland D, Kiehlbauch JA, Terry PM, Wachsmuth IK. Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 1992 ; 30 : 362-9.
60. 60 Centers for Diseases Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995 ; 16 : 105-13.
61. 61 Centre de Coordination des CLIN de l'interrégion Paris Nord et CLIN central de l'Assistance publique-hôpitaux de Paris. Programme national de maîtrise de la diffusion des bactéries multirésistantes. Paris : Documentation du Comité technique national des infections nosocomiales ; 1998.
62. e édition. Paris : Documentation du ministère de la Santé ; 1998.
63. 63 Agence nationale pour le développement et l'évaluation médicale. Le bon usage des antibiotiques à l'hôpital. Paris, 1996.